Health diagnostics: Key investors at each stage

17/04/2020
Diego Gutiérrez
Health diagnostics: Key investors at each stage

In this post we are going to analyse the most important investors in the health diagnostics sector, classified according to the stage the investee companies were in at the time of investment, i.e. whether they were companies in Seed Stage and Early Stage

The Health Diagnostics o Diagnósticos de Salud includes all those companies dedicated to the development of techniques and instruments that facilitate the early diagnosis of pathologies and/or diseases and enable action to be taken against them as soon as possible.

Seed Stage: SOSV

health diagnostics

SOSV is an investment management and venture capital firm that provides seed, venture and growth stage financing to start-ups in the technology sector. Its main focus is on accelerating the growth of technology start-ups. startups through specific programmes, called Seed Acceleratorsin Europe, Asia and the United States.

2018 and 2019 were the years in which SOSV made the most investments in the health diagnostics sector, with a total of 13 investments in Seed Stagewhile in Late Stage only 8 investments were made. In addition, the main destination of funds was the United States, followed by Ireland and Canada. 

For example, in 2019 it took part in a round of the stage. Seed of the US startup Sentio Solutions (Feel), dedicated to the development of technologies for the diagnosis of mental health conditions. It invested $4.5 million in this company. In addition, in 2016 it financed with €1.6 million the growth stage of the company. Seed of the Irish company Metabolomic Diagnostics, dedicated to the development of methods for the diagnosis of pre-eclampsia in pregnancy.

Early Stage: 8VC

 Eight Partners VC, LLC (8VC) is a technology investment company, specialising primarily in investments in companies in Early Stages. It is a smaller company in volume than the previous one, SOSV, and this is why its activity is mainly focused on the United States. Despite the geographical limitation, it is very active in investing in US startups, with a total of 10 participations in rounds of Early Stage of different technology companies in the last year.

One of the most important investments in the health diagnostics sector was the one in Guardant Health, a start-up company dedicated to research and development of blood tests for oncology patients. In 2017 it participated in the "Series E" round with 360 million dollars.

▶You may be interested in: Best investors in health diagnostics.

Lastest news

State of technology M&A in Spain | Analysis August 2025

El mes de agosto, tradicionalmente más pausado en cuanto a transacciones corporativas, ha sorprendido en 2025 con una intensa actividad en el ámbito tecnológico en España. Se registraron operaciones de gran calado en segmentos como marketplaces digitales,...

Baker Tilly advises BSG on its acquisition of Copermática

The advisors for the sale and purchase of technology companies at Baker Tilly Tech M&A have advised Business Software Group (BSG) on its recent acquisition of Copermática, a company specialising in management software for professional firms and consultancies. With...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

    On which topic would you like to receive information?

    Request for information

    If you want to buy or sell a company, or need more information about our services, do not hesitate to contact us through the form.

    Or if you prefer, call us at:

    +34 946 42 41 42